Search published articles


Showing 2 results for Diagnostic

Pedram Torabian, Dr Vahid Erfani-Moghadam,
Volume 4, Issue 1 (5-2016)
Abstract

For decades, researchers have tried to develop non-invasive mechanisms for monitoring pathological conditions within the body of patients. Emerging nanotechnology enabled us to reach this aim. Scale of nano has the potential to increase early detection of pathological conditions among abnormal cells before diseased tissue or tumor development can be considerable which is helpful in disease treatment. In recent years, “Theranostics” has been emerged as a novel nano approach which performs diagnostic detection, therapy and follows up simultaneously. Therefore, Theranostics can be considered as an appropriate therapeutic approach for personalized medicine, pharmacogenomics and molecular imaging which can open a gate to develop novel therapies. Additionally, with a deeper molecular understanding, choosing drugs that are more effective will be possible. Finally, researchers believe that Theranostics has the potential to monitor treatments by increasing drug effectiveness and preventing inappropriate treatments and consequently reducing the cost of national health burden. In this review, structure and some applications of Theranostics and nano drug delivery systems have been discussed briefly.


Milad Ahmad-Aghdami , Saeed Mohammadi ,
Volume 13, Issue 1 (9-2025)
Abstract

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease characterized by heterogeneous clinical manifestations and the production of autoantibodies, making early diagnosis challenging. Traditional diagnostic methods lack sensitivity and specificity, leading to delayed intervention and irreversible organ damage. Single-cell technologies offer a novel opportunity to investigate the cellular landscape of SLE at the level of individual cells. By profiling the gene expression, protein expression, and functional states of thousands of individual cells simultaneously, these technologies can reveal critical findings such as the expansion of type I interferon-producing pDCs and dysregulated T/B cell subsets involved in SLE pathogenesis. This editorial highlights the transformative potential of single-cell analysis in identifying disease-relevant cell populations and their functional states, ultimately paving the way for earlier diagnosis, personalized treatment, and improved outcomes for patients with SLE.


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb